Business Context and Reporting Period
This Form 8-K filing by Bristol-Myers Squibb Company, dated October 31, 2006, reports material definitive agreements regarding executive leadership transitions. The filing details the separation of former CEO Peter R. Dolan, the appointment of James M. Cornelius as Interim CEO, and the departure of Senior Vice President Richard K. Willard.
Key Financial Metrics and Agreements
The filing outlines specific compensation and severance packages rather than general corporate financial performance metrics.
- Peter R. Dolan (Former CEO):
- Severance: $1,237,981 gross cash (51.5 weeks of base salary).
- Pension Benefits: Present value of approximately $9,480,000.
- Equity: Accelerated vesting of 763,125 stock options; extended exercise terms for 2,336,369 vested options; vesting of 81,013 restricted shares.
- Consulting Fee: $50,000 monthly through April 30, 2007.
- Other: Up to $75,000 for outplacement and $25,000 for transition services.
- James M. Cornelius (Interim CEO):
- Base Salary: $1,250,000 annually.
- Target Bonus: 170% of base salary for up to 15 months.
- Guaranteed Bonus: 6 months of target bonus if serving until March 31, 2007 or successor start date.
- Equity: Option to purchase 360,000 shares (50% vests by March 31, 2007).
- Perks: Leased NYC apartment ($25,500/month), company aircraft, and car/driver.
- Richard K. Willard (Former SVP/General Counsel):
- Severance: $1,428,000 gross cash (2x base salary).
- Equity: All stock options, restricted stock, and performance awards forfeited.
Material Changes Versus Prior Period
The primary material change is the cessation of Peter R. Dolan's service as CEO effective October 31, 2006, following his announcement of departure on September 12, 2006. James M. Cornelius was appointed Interim CEO on September 12, 2006, with formal compensation terms approved on October 31, 2006. Richard K. Willard ceased service as SVP and General Counsel on September 28, 2006.
Outlook, Risks, and Contingencies
Management Commentary and Conditions:
- Forfeiture Clauses: Mr. Dolan's severance and benefits are contingent on the absence of willful misconduct or activity detrimental to the Company. If such conduct is determined, he must refund payments exceeding standard entitlements.
- Restrictive Covenants: Mr. Dolan has agreed to non-compete and non-solicit restrictions for one year and a non-disparagement clause for three years. He also agreed not to assist third parties seeking control of the Company for one year.
- Performance Criteria: Mr. Cornelius's remaining bonus (9 months) is subject to performance criteria under the 2007 Performance Incentive Plan. His stock option vesting is tied to continued employment or the appointment of a successor.
- Change in Control: Mr. Cornelius is entitled to prorated bonus payments, full option vesting, and excise tax gross-ups in the event of a Change in Control followed by termination.
Financial Metrics: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Key Facts for Investor Verification
- Verify the total cash outflow for executive severance ($1,237,981 for Dolan; $1,428,000 for Willard) and the present value of pension liabilities ($9,480,000 for Dolan).
- Confirm the timeline for the appointment of a permanent CEO to determine the vesting schedule of Mr. Cornelius's stock options and bonus structure.
- Review the specific performance thresholds for Mr. Cornelius's variable compensation under the 2007 Performance Incentive Plan.
- Monitor the consulting arrangement with Mr. Dolan through April 30, 2007, and associated monthly fees.
- Assess the impact of the forfeiture of Mr. Willard's equity awards on total compensation expense.